Rank | Gene Set | Z-score |
---|---|---|
1 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 9.99374969 |
2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 9.99374969 |
3 | * leukocyte migration involved in inflammatory response (GO:0002523) | 9.07259067 |
4 | * leukocyte aggregation (GO:0070486) | 8.99559717 |
5 | * defense response to fungus (GO:0050832) | 8.31178354 |
6 | response to peptidoglycan (GO:0032494) | 7.90795279 |
7 | disruption of cells of other organism (GO:0044364) | 7.53484258 |
8 | killing of cells of other organism (GO:0031640) | 7.53484258 |
9 | respiratory burst (GO:0045730) | 7.31857592 |
10 | * response to fungus (GO:0009620) | 7.14327517 |
11 | neutrophil mediated immunity (GO:0002446) | 7.11727760 |
12 | negative regulation of cell killing (GO:0031342) | 6.91509068 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.91509068 |
14 | cellular extravasation (GO:0045123) | 6.85290189 |
15 | neutrophil activation involved in immune response (GO:0002283) | 6.41855457 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.11671627 |
17 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.06290097 |
18 | positive regulation by symbiont of host defense response (GO:0052509) | 5.94787305 |
19 | modulation by symbiont of host defense response (GO:0052031) | 5.94787305 |
20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.94787305 |
21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.94787305 |
22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.94787305 |
23 | modulation by symbiont of host immune response (GO:0052553) | 5.94787305 |
24 | detection of bacterium (GO:0016045) | 5.78049162 |
25 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.72095298 |
26 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 5.65291536 |
27 | * sequestering of metal ion (GO:0051238) | 5.61699998 |
28 | pentose-phosphate shunt (GO:0006098) | 5.61329862 |
29 | neutrophil activation (GO:0042119) | 5.59439261 |
30 | superoxide anion generation (GO:0042554) | 5.53224219 |
31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.48888461 |
32 | regulation of leukocyte degranulation (GO:0043300) | 5.41645780 |
33 | reactive oxygen species biosynthetic process (GO:1903409) | 5.39911097 |
34 | myeloid leukocyte mediated immunity (GO:0002444) | 5.37532469 |
35 | detection of other organism (GO:0098543) | 5.35972879 |
36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.26125348 |
37 | macrophage differentiation (GO:0030225) | 5.20619333 |
38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.18672417 |
39 | granulocyte activation (GO:0036230) | 5.16326135 |
40 | macrophage activation involved in immune response (GO:0002281) | 5.10846076 |
41 | NADPH regeneration (GO:0006740) | 5.02490565 |
42 | leukotriene metabolic process (GO:0006691) | 4.96099297 |
43 | regulation of regulated secretory pathway (GO:1903305) | 4.88743000 |
44 | phagosome maturation (GO:0090382) | 4.87859536 |
45 | positive regulation of mast cell activation (GO:0033005) | 4.82645279 |
46 | leukotriene biosynthetic process (GO:0019370) | 4.80482168 |
47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66052688 |
48 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.65346471 |
49 | detection of molecule of bacterial origin (GO:0032490) | 4.61949798 |
50 | detection of biotic stimulus (GO:0009595) | 4.59648569 |
51 | regulation of mast cell degranulation (GO:0043304) | 4.55247288 |
52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.52412488 |
53 | mucosal immune response (GO:0002385) | 4.49855431 |
54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.46447025 |
55 | positive regulation of mast cell degranulation (GO:0043306) | 4.46447025 |
56 | adaptation of signaling pathway (GO:0023058) | 4.44052835 |
57 | * neutrophil chemotaxis (GO:0030593) | 4.41171132 |
58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.38886060 |
59 | * neutrophil migration (GO:1990266) | 4.29092811 |
60 | innate immune response in mucosa (GO:0002227) | 4.25429215 |
61 | organ or tissue specific immune response (GO:0002251) | 4.25324164 |
62 | cell killing (GO:0001906) | 4.25175738 |
63 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.24802321 |
64 | immunoglobulin mediated immune response (GO:0016064) | 4.24416307 |
65 | regulation of mast cell activation (GO:0033003) | 4.21744589 |
66 | antibacterial humoral response (GO:0019731) | 4.21437238 |
67 | response to host immune response (GO:0052572) | 4.18156454 |
68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.18156454 |
69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.16223502 |
70 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14926952 |
71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.12497277 |
72 | microglial cell activation (GO:0001774) | 4.11325344 |
73 | antimicrobial humoral response (GO:0019730) | 4.10719327 |
74 | * granulocyte migration (GO:0097530) | 4.04675865 |
75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.98475681 |
76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.95020746 |
77 | * chronic inflammatory response (GO:0002544) | 3.92150775 |
78 | response to host defenses (GO:0052200) | 3.90537058 |
79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.90537058 |
80 | response to host (GO:0075136) | 3.90537058 |
81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.90433679 |
82 | myeloid cell activation involved in immune response (GO:0002275) | 3.90344142 |
83 | macrophage activation (GO:0042116) | 3.89828326 |
84 | regulation of gamma-delta T cell activation (GO:0046643) | 3.89726098 |
85 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.88791088 |
86 | negative regulation of phagocytosis (GO:0050765) | 3.88585498 |
87 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.88279668 |
88 | regulation of growth of symbiont in host (GO:0044126) | 3.88279668 |
89 | negative regulation of growth of symbiont in host (GO:0044130) | 3.88279668 |
90 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.88279668 |
91 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.85330396 |
92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.73206166 |
93 | defense response to Gram-positive bacterium (GO:0050830) | 3.72308375 |
94 | positive regulation of lamellipodium assembly (GO:0010592) | 3.71932237 |
95 | * granulocyte chemotaxis (GO:0071621) | 3.70038193 |
96 | glucose catabolic process (GO:0006007) | 3.69553587 |
97 | negative regulation of interleukin-10 production (GO:0032693) | 3.67771819 |
98 | response to interleukin-15 (GO:0070672) | 3.53502014 |
99 | negative regulation of interleukin-12 production (GO:0032695) | 3.53460299 |
100 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53455730 |
101 | positive regulation of leukocyte degranulation (GO:0043302) | 3.51065165 |
102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.47238760 |
103 | * leukocyte cell-cell adhesion (GO:0007159) | 3.43643629 |
104 | cellular response to type I interferon (GO:0071357) | 3.43391330 |
105 | type I interferon signaling pathway (GO:0060337) | 3.43391330 |
106 | response to type I interferon (GO:0034340) | 3.39521092 |
107 | leukocyte degranulation (GO:0043299) | 3.33101043 |
108 | B cell mediated immunity (GO:0019724) | 3.31691940 |
109 | actin nucleation (GO:0045010) | 3.30138793 |
110 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.25897539 |
111 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.25897539 |
112 | defense response to protozoan (GO:0042832) | 3.24778861 |
113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.24771494 |
114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.24631558 |
115 | B cell receptor signaling pathway (GO:0050853) | 3.24097419 |
116 | positive regulation of regulated secretory pathway (GO:1903307) | 3.23618229 |
117 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.19348114 |
118 | NADP metabolic process (GO:0006739) | 3.18393582 |
119 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18354850 |
120 | germinal center formation (GO:0002467) | 3.17852375 |
121 | negative regulation of interleukin-6 production (GO:0032715) | 3.16644237 |
122 | mast cell activation (GO:0045576) | 3.11914944 |
123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11751863 |
124 | regulation of tolerance induction (GO:0002643) | 3.11595179 |
125 | pentose metabolic process (GO:0019321) | 3.11132429 |
126 | * defense response to bacterium (GO:0042742) | 3.08623482 |
127 | interaction with symbiont (GO:0051702) | 3.06195676 |
128 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 3.05402197 |
129 | negative regulation of innate immune response (GO:0045824) | 3.04984326 |
130 | myeloid leukocyte activation (GO:0002274) | 3.03781100 |
131 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02722697 |
132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01367342 |
133 | cellular response to interleukin-15 (GO:0071350) | 3.00973169 |
134 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00895938 |
135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00606311 |
136 | detection of external biotic stimulus (GO:0098581) | 2.99693391 |
137 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99683529 |
138 | positive regulation of osteoblast proliferation (GO:0033690) | 2.98505388 |
139 | regulation of T cell tolerance induction (GO:0002664) | 2.98366871 |
140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.96876909 |
141 | response to muramyl dipeptide (GO:0032495) | 2.95302526 |
142 | positive regulation of lamellipodium organization (GO:1902745) | 2.95008073 |
143 | regulation of natural killer cell differentiation (GO:0032823) | 2.94839680 |
144 | positive regulation of interleukin-4 production (GO:0032753) | 2.94651541 |
145 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.93867304 |
146 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93595285 |
147 | positive regulation of B cell differentiation (GO:0045579) | 2.93282065 |
148 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93207597 |
149 | negative regulation of type 2 immune response (GO:0002829) | 2.92585001 |
150 | * myeloid leukocyte migration (GO:0097529) | 2.91456366 |
151 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91130702 |
152 | activated T cell proliferation (GO:0050798) | 2.89843397 |
153 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.84042686 |
154 | eosinophil migration (GO:0072677) | 2.83510225 |
155 | regulation of phagocytosis (GO:0050764) | 2.81264892 |
156 | regulation of B cell differentiation (GO:0045577) | 2.80054108 |
157 | phospholipid homeostasis (GO:0055091) | 2.78833543 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.54303782 |
2 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.84011512 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.54631433 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.45045697 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.20055066 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.63236871 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.52092316 |
8 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.43897384 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.40209689 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32641380 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.31050200 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10849158 |
13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.07906140 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02401311 |
15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.87233324 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69719880 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68000862 |
18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.64044839 |
19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.36866673 |
20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.26661537 |
21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.26632084 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.25919038 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23879883 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 2.19015980 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.17808779 |
26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13160852 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12971613 |
28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.10652171 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.07747581 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.97536603 |
31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89098757 |
32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86805715 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86406390 |
34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82901302 |
35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80336860 |
36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76844838 |
37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74298272 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73991658 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73859360 |
40 | MYB_26560356_Chip-Seq_TH1_Human | 1.73303026 |
41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71917564 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68436945 |
43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62736086 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62094685 |
45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61795419 |
46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51719340 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51377488 |
48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50743857 |
49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50737821 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50363419 |
51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49406210 |
52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48696618 |
53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47020208 |
54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45096949 |
55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44443599 |
56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43961156 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40716016 |
58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40476926 |
59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40267357 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40030318 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36891881 |
62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35165495 |
63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34244800 |
64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29734890 |
65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29714396 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.29291923 |
67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29154498 |
68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28180191 |
69 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26643610 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26174327 |
71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25973112 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25153487 |
73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24611166 |
74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24229919 |
75 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.22687149 |
76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19410543 |
77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15626292 |
78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15237390 |
79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13195305 |
80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12840212 |
81 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11067178 |
82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10627354 |
83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10358813 |
84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09023621 |
85 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08922389 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08315460 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06973526 |
88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05597618 |
89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05344273 |
90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04759742 |
91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03495753 |
92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00473438 |
93 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98450643 |
94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97737874 |
95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97580559 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95270582 |
97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94181585 |
98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94003898 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93522580 |
100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92872117 |
101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92420148 |
102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91889985 |
103 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91415521 |
104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90962205 |
105 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89376369 |
106 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88229871 |
107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87782063 |
108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87266867 |
109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83456727 |
110 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82701173 |
111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.79764106 |
112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79065676 |
113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78846410 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 6.88254897 |
2 | MP0003436_decreased_susceptibility_to | 5.17342556 |
3 | MP0003183_abnormal_peptide_metabolism | 4.48974528 |
4 | MP0009278_abnormal_bone_marrow | 3.82185587 |
5 | * MP0002419_abnormal_innate_immunity | 3.36282610 |
6 | * MP0009785_altered_susceptibility_to | 3.18940712 |
7 | MP0001533_abnormal_skeleton_physiology | 2.78359779 |
8 | MP0005464_abnormal_platelet_physiology | 2.51231823 |
9 | * MP0005025_abnormal_response_to | 2.50464578 |
10 | MP0001851_eye_inflammation | 2.48303862 |
11 | MP0003724_increased_susceptibility_to | 2.39798377 |
12 | MP0000343_altered_response_to | 2.38580509 |
13 | MP0003300_gastrointestinal_ulcer | 2.36286565 |
14 | MP0000465_gastrointestinal_hemorrhage | 2.33102419 |
15 | MP0008260_abnormal_autophagy | 2.30995737 |
16 | MP0002405_respiratory_system_inflammati | 2.24430876 |
17 | MP0005000_abnormal_immune_tolerance | 2.21412689 |
18 | MP0005397_hematopoietic_system_phenotyp | 2.12174763 |
19 | MP0001545_abnormal_hematopoietic_system | 2.12174763 |
20 | MP0002837_dystrophic_cardiac_calcinosis | 2.09704400 |
21 | MP0000685_abnormal_immune_system | 2.04628448 |
22 | * MP0002420_abnormal_adaptive_immunity | 2.03889011 |
23 | * MP0001819_abnormal_immune_cell | 2.02656776 |
24 | MP0002452_abnormal_antigen_presenting | 1.97512335 |
25 | MP0002132_abnormal_respiratory_system | 1.90289650 |
26 | MP0001800_abnormal_humoral_immune | 1.89760175 |
27 | MP0001835_abnormal_antigen_presentation | 1.81274826 |
28 | MP0003763_abnormal_thymus_physiology | 1.81233461 |
29 | MP0001853_heart_inflammation | 1.80767777 |
30 | MP0004808_abnormal_hematopoietic_stem | 1.79796933 |
31 | * MP0001845_abnormal_inflammatory_respons | 1.77982921 |
32 | MP0004883_abnormal_blood_vessel | 1.76748736 |
33 | MP0002148_abnormal_hypersensitivity_rea | 1.76362452 |
34 | MP0005387_immune_system_phenotype | 1.73026218 |
35 | MP0001790_abnormal_immune_system | 1.73026218 |
36 | * MP0002723_abnormal_immune_serum | 1.71237467 |
37 | MP0003075_altered_response_to | 1.70314868 |
38 | MP0003656_abnormal_erythrocyte_physiolo | 1.67596557 |
39 | MP0003566_abnormal_cell_adhesion | 1.67593347 |
40 | MP0005167_abnormal_blood-brain_barrier | 1.61106411 |
41 | MP0002398_abnormal_bone_marrow | 1.58891100 |
42 | MP0000858_altered_metastatic_potential | 1.54584420 |
43 | MP0005451_abnormal_body_composition | 1.52178120 |
44 | MP0003172_abnormal_lysosome_physiology | 1.52045607 |
45 | MP0003866_abnormal_defecation | 1.51175346 |
46 | * MP0000716_abnormal_immune_system | 1.46910282 |
47 | MP0005058_abnormal_lysosome_morphology | 1.46415511 |
48 | MP0000569_abnormal_digit_pigmentation | 1.45646358 |
49 | MP0004381_abnormal_hair_follicle | 1.44907299 |
50 | MP0002277_abnormal_respiratory_mucosa | 1.41019799 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.39675239 |
52 | MP0002933_joint_inflammation | 1.38900274 |
53 | MP0004947_skin_inflammation | 1.36656618 |
54 | MP0002396_abnormal_hematopoietic_system | 1.35749885 |
55 | MP0009764_decreased_sensitivity_to | 1.31106830 |
56 | MP0005023_abnormal_wound_healing | 1.29091330 |
57 | MP0005164_abnormal_response_to | 1.28129465 |
58 | MP0010155_abnormal_intestine_physiology | 1.27555443 |
59 | * MP0002429_abnormal_blood_cell | 1.27184607 |
60 | MP0001958_emphysema | 1.26583993 |
61 | MP0005076_abnormal_cell_differentiation | 1.25187376 |
62 | MP0002722_abnormal_immune_system | 1.24700600 |
63 | MP0002998_abnormal_bone_remodeling | 1.22891798 |
64 | MP0000689_abnormal_spleen_morphology | 1.21719072 |
65 | MP0002928_abnormal_bile_duct | 1.15353186 |
66 | MP0001873_stomach_inflammation | 1.15293758 |
67 | MP0005390_skeleton_phenotype | 1.13428839 |
68 | MP0003690_abnormal_glial_cell | 1.09376486 |
69 | MP0003191_abnormal_cellular_cholesterol | 1.09348399 |
70 | * MP0008469_abnormal_protein_level | 1.07838535 |
71 | MP0003448_altered_tumor_morphology | 1.07427352 |
72 | MP0005174_abnormal_tail_pigmentation | 1.03945579 |
73 | MP0003828_pulmonary_edema | 1.03658305 |
74 | MP0001663_abnormal_digestive_system | 1.02823134 |
75 | MP0003693_abnormal_embryo_hatching | 0.99437576 |
76 | MP0005671_abnormal_response_to | 0.94877514 |
77 | MP0002282_abnormal_trachea_morphology | 0.88186745 |
78 | MP0005388_respiratory_system_phenotype | 0.87734898 |
79 | MP0002133_abnormal_respiratory_system | 0.87734898 |
80 | MP0005083_abnormal_biliary_tract | 0.85808916 |
81 | MP0002877_abnormal_melanocyte_morpholog | 0.83196148 |
82 | MP0008004_abnormal_stomach_pH | 0.82541528 |
83 | MP0000703_abnormal_thymus_morphology | 0.82402904 |
84 | MP0005166_decreased_susceptibility_to | 0.81700710 |
85 | MP0010307_abnormal_tumor_latency | 0.81315291 |
86 | MP0001986_abnormal_taste_sensitivity | 0.81132552 |
87 | MP0002166_altered_tumor_susceptibility | 0.79948474 |
88 | MP0003279_aneurysm | 0.79449045 |
89 | MP0000604_amyloidosis | 0.76502997 |
90 | MP0004510_myositis | 0.75699856 |
91 | MP0009840_abnormal_foam_cell | 0.74121376 |
92 | MP0006082_CNS_inflammation | 0.73673992 |
93 | MP0000920_abnormal_myelination | 0.72997733 |
94 | MP0003123_paternal_imprinting | 0.72961448 |
95 | MP0003806_abnormal_nucleotide_metabolis | 0.72634038 |
96 | MP0009763_increased_sensitivity_to | 0.72443439 |
97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70976304 |
98 | MP0002089_abnormal_postnatal_growth/wei | 0.69829317 |
99 | MP0000249_abnormal_blood_vessel | 0.68772957 |
100 | MP0005075_abnormal_melanosome_morpholog | 0.68465486 |
101 | MP0009931_abnormal_skin_appearance | 0.67099637 |
102 | MP0003453_abnormal_keratinocyte_physiol | 0.66469840 |
103 | MP0003329_amyloid_beta_deposits | 0.65738007 |
104 | MP0003878_abnormal_ear_physiology | 0.65184120 |
105 | MP0005377_hearing/vestibular/ear_phenot | 0.65184120 |
106 | MP0009765_abnormal_xenobiotic_induced | 0.64353084 |
107 | MP0005381_digestive/alimentary_phenotyp | 0.64083844 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.63768977 |
109 | MP0000490_abnormal_crypts_of | 0.63351462 |
110 | MP0008874_decreased_physiological_sensi | 0.63279980 |
111 | MP0005310_abnormal_salivary_gland | 0.62292087 |
112 | MP0002138_abnormal_hepatobiliary_system | 0.62232172 |
113 | MP0004264_abnormal_extraembryonic_tissu | 0.62030866 |
114 | MP0002796_impaired_skin_barrier | 0.61591353 |
115 | MP0010352_gastrointestinal_tract_polyps | 0.61226967 |
116 | MP0001216_abnormal_epidermal_layer | 0.60351906 |
117 | MP0003045_fibrosis | 0.57960436 |
118 | MP0002006_tumorigenesis | 0.57199993 |
119 | MP0002060_abnormal_skin_morphology | 0.56836857 |
120 | MP0003795_abnormal_bone_structure | 0.56322728 |
121 | MP0000015_abnormal_ear_pigmentation | 0.54604697 |
122 | MP0002019_abnormal_tumor_incidence | 0.54055730 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent gram-negative bacterial infections (HP:0005420) | 9.89473561 |
2 | Recurrent bacterial skin infections (HP:0005406) | 9.29416857 |
3 | Obstructive lung disease (HP:0006536) | 7.03360703 |
4 | Chronic obstructive pulmonary disease (HP:0006510) | 7.03360703 |
5 | Gingivitis (HP:0000230) | 6.17580062 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 6.03007739 |
7 | Abnormality of macrophages (HP:0004311) | 5.95947024 |
8 | Recurrent skin infections (HP:0001581) | 5.30351000 |
9 | Recurrent fungal infections (HP:0002841) | 5.14077570 |
10 | Retrobulbar optic neuritis (HP:0100654) | 5.08196598 |
11 | Optic neuritis (HP:0100653) | 5.08196598 |
12 | Cellulitis (HP:0100658) | 5.05982833 |
13 | Urticaria (HP:0001025) | 4.82801207 |
14 | Stomatitis (HP:0010280) | 4.34303474 |
15 | Spontaneous hematomas (HP:0007420) | 4.04241308 |
16 | Meningitis (HP:0001287) | 4.00789350 |
17 | Keratoconjunctivitis (HP:0001096) | 3.64417245 |
18 | Myositis (HP:0100614) | 3.59743955 |
19 | Episodic fever (HP:0001954) | 3.31351461 |
20 | Abnormal platelet volume (HP:0011876) | 3.10271885 |
21 | Papilledema (HP:0001085) | 3.02990996 |
22 | Osteomyelitis (HP:0002754) | 2.99031966 |
23 | Anorexia (HP:0002039) | 2.98153404 |
24 | Periodontitis (HP:0000704) | 2.94109834 |
25 | Sepsis (HP:0100806) | 2.92996093 |
26 | Recurrent pneumonia (HP:0006532) | 2.90807040 |
27 | Amyloidosis (HP:0011034) | 2.85116311 |
28 | Pulmonary infiltrates (HP:0002113) | 2.84335692 |
29 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68336033 |
30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68336033 |
31 | Gangrene (HP:0100758) | 2.61124772 |
32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56441465 |
33 | Increased mean platelet volume (HP:0011877) | 2.54222032 |
34 | Hypochromic microcytic anemia (HP:0004840) | 2.52362429 |
35 | Metaphyseal cupping (HP:0003021) | 2.50866391 |
36 | Premature loss of primary teeth (HP:0006323) | 2.50718006 |
37 | Pustule (HP:0200039) | 2.50374645 |
38 | Increased IgE level (HP:0003212) | 2.50361029 |
39 | Absent frontal sinuses (HP:0002688) | 2.49861247 |
40 | IgM deficiency (HP:0002850) | 2.49048987 |
41 | Epistaxis (HP:0000421) | 2.48552207 |
42 | Recurrent viral infections (HP:0004429) | 2.45723807 |
43 | Skin ulcer (HP:0200042) | 2.45077244 |
44 | Increased IgM level (HP:0003496) | 2.42731639 |
45 | Prolonged bleeding time (HP:0003010) | 2.40854186 |
46 | T lymphocytopenia (HP:0005403) | 2.39938934 |
47 | Abnormality of T cell number (HP:0011839) | 2.37762253 |
48 | Panhypogammaglobulinemia (HP:0003139) | 2.37593298 |
49 | Vacuolated lymphocytes (HP:0001922) | 2.37289811 |
50 | Interstitial pulmonary disease (HP:0006530) | 2.36101968 |
51 | Hypergammaglobulinemia (HP:0010702) | 2.36064269 |
52 | Petechiae (HP:0000967) | 2.35247443 |
53 | Gingival bleeding (HP:0000225) | 2.34998389 |
54 | Chest pain (HP:0100749) | 2.34931491 |
55 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32724420 |
56 | Difficulty running (HP:0009046) | 2.31776624 |
57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29694343 |
58 | Leukocytosis (HP:0001974) | 2.28669815 |
59 | Abnormality of T cells (HP:0002843) | 2.27710350 |
60 | Orchitis (HP:0100796) | 2.23426514 |
61 | Abnormality of the pleura (HP:0002103) | 2.21670858 |
62 | Increased serum ferritin (HP:0003281) | 2.20787291 |
63 | Colitis (HP:0002583) | 2.20123142 |
64 | Vasculitis (HP:0002633) | 2.19717771 |
65 | Abnormality of the peritoneum (HP:0002585) | 2.19680151 |
66 | Hypermelanotic macule (HP:0001034) | 2.18814343 |
67 | Hemoptysis (HP:0002105) | 2.18107824 |
68 | Cheilitis (HP:0100825) | 2.16674883 |
69 | Malnutrition (HP:0004395) | 2.13158649 |
70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10386760 |
71 | Cutaneous photosensitivity (HP:0000992) | 2.08145405 |
72 | Abnormality of the endocardium (HP:0004306) | 2.06634646 |
73 | Purpura (HP:0000979) | 2.05327560 |
74 | Pulmonary embolism (HP:0002204) | 2.01844872 |
75 | Eczematoid dermatitis (HP:0000976) | 10.9385269 |
76 | Recurrent abscess formation (HP:0002722) | 10.2618760 |
77 | Thickened calvaria (HP:0002684) | 1.99987820 |
78 | Systemic lupus erythematosus (HP:0002725) | 1.99918989 |
79 | Abnormality of iron homeostasis (HP:0011031) | 1.99378883 |
80 | Microcytic anemia (HP:0001935) | 1.99167154 |
81 | Acne (HP:0001061) | 1.98574681 |
82 | Keratitis (HP:0000491) | 1.98258594 |
83 | Increased cerebral lipofuscin (HP:0011813) | 1.97532084 |
84 | Increased density of long bones (HP:0006392) | 1.97127363 |
85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97101290 |
86 | Autoimmune thrombocytopenia (HP:0001973) | 1.96126625 |
87 | Glomerulopathy (HP:0100820) | 1.95877038 |
88 | Hepatosplenomegaly (HP:0001433) | 1.95568044 |
89 | Inflammation of the large intestine (HP:0002037) | 1.95355829 |
90 | Loss of speech (HP:0002371) | 1.93157065 |
91 | Menorrhagia (HP:0000132) | 1.93116486 |
92 | Vertigo (HP:0002321) | 1.92746777 |
93 | Skin rash (HP:0000988) | 1.92478007 |
94 | Hematochezia (HP:0002573) | 1.91449509 |
95 | Peritonitis (HP:0002586) | 1.90904365 |
96 | Chronic otitis media (HP:0000389) | 1.90510244 |
97 | Eosinophilia (HP:0001880) | 1.89968551 |
98 | Papilloma (HP:0012740) | 1.89548205 |
99 | Verrucae (HP:0200043) | 1.89548205 |
100 | Syringomyelia (HP:0003396) | 1.88811844 |
101 | Spinal cord lesions (HP:0100561) | 1.88811844 |
102 | Gastrointestinal inflammation (HP:0004386) | 1.88312431 |
103 | Pyloric stenosis (HP:0002021) | 1.87287643 |
104 | Acute hepatic failure (HP:0006554) | 1.85135219 |
105 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83432412 |
106 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83432412 |
107 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83432412 |
108 | Spondylolisthesis (HP:0003302) | 1.81522931 |
109 | Impaired platelet aggregation (HP:0003540) | 1.81466956 |
110 | Abnormal platelet function (HP:0011869) | 1.81466956 |
111 | Muscle fiber splitting (HP:0003555) | 1.79715333 |
112 | Viral hepatitis (HP:0006562) | 1.78951997 |
113 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78796976 |
114 | Short 4th metacarpal (HP:0010044) | 1.77653983 |
115 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.77653983 |
116 | Slow saccadic eye movements (HP:0000514) | 1.77109660 |
117 | Granulocytopenia (HP:0001913) | 1.73652880 |
118 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.72513182 |
119 | Osteolytic defects of the hand bones (HP:0009699) | 1.69911026 |
120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69911026 |
121 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.69653938 |
122 | Hypochromic anemia (HP:0001931) | 1.68690103 |
123 | Gastrointestinal infarctions (HP:0005244) | 1.68011219 |
124 | Keratoconjunctivitis sicca (HP:0001097) | 1.67114091 |
125 | Abnormal foot bone ossification (HP:0010675) | 1.66569665 |
126 | Lymphopenia (HP:0001888) | 1.62425538 |
127 | Dysostosis multiplex (HP:0000943) | 1.60214225 |
128 | Encephalitis (HP:0002383) | 1.58243272 |
129 | Restrictive lung disease (HP:0002091) | 1.56854780 |
130 | Thoracic kyphosis (HP:0002942) | 1.55432407 |
131 | Abnormality of the frontal sinuses (HP:0002687) | 1.55214173 |
132 | Persistence of primary teeth (HP:0006335) | 1.55050118 |
133 | Ulnar deviation of the wrist (HP:0003049) | 1.54426078 |
134 | Thyroiditis (HP:0100646) | 1.54064858 |
135 | Abnormality of T cell physiology (HP:0011840) | 1.53127707 |
136 | Myelodysplasia (HP:0002863) | 1.52239382 |
137 | Polygenic inheritance (HP:0010982) | 1.51019785 |
138 | Short femoral neck (HP:0100864) | 1.48468372 |
139 | Arterial thrombosis (HP:0004420) | 1.48393819 |
140 | Recurrent sinusitis (HP:0011108) | 1.48295475 |
141 | Ulnar bowing (HP:0003031) | 1.48285121 |
142 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.48270743 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK4 | 6.35905614 |
2 | EPHB1 | 4.17861534 |
3 | RIPK4 | 3.45140392 |
4 | BLK | 3.22552484 |
5 | FES | 3.03768948 |
6 | CSK | 2.92861840 |
7 | GRK6 | 2.81223713 |
8 | FGR | 2.76354102 |
9 | ERN1 | 2.68447435 |
10 | TTN | 2.49925576 |
11 | TRPM7 | 2.28411002 |
12 | TESK2 | 2.28297620 |
13 | BTK | 2.25891759 |
14 | CLK1 | 2.18287449 |
15 | STK10 | 2.16248418 |
16 | PRPF4B | 2.07763073 |
17 | TRIB3 | 1.97016279 |
18 | MAP4K1 | 1.95419820 |
19 | MAP3K9 | 1.83928796 |
20 | MAP2K3 | 1.83778407 |
21 | TESK1 | 1.79543405 |
22 | JAK3 | 1.74180280 |
23 | HCK | 1.73052427 |
24 | MAP3K12 | 1.72891210 |
25 | PRKG2 | 1.71768477 |
26 | TEC | 1.53459251 |
27 | ALK | 1.52511295 |
28 | LRRK2 | 1.48331841 |
29 | PAK4 | 1.45758118 |
30 | ERBB3 | 1.44416603 |
31 | PTK6 | 1.37613190 |
32 | SIK3 | 1.35580003 |
33 | ZAP70 | 1.33363906 |
34 | MAP3K13 | 1.19737405 |
35 | PKN2 | 1.16698645 |
36 | MARK2 | 1.09992378 |
37 | MAPK4 | 1.08041882 |
38 | SYK | 1.04485834 |
39 | PRKD2 | 1.04244149 |
40 | KSR2 | 1.02977035 |
41 | MAP2K6 | 1.02619294 |
42 | NEK2 | 0.99969638 |
43 | IRAK1 | 0.97185312 |
44 | PTK2 | 0.96792400 |
45 | MAP2K4 | 0.96593642 |
46 | MAP3K11 | 0.95976303 |
47 | TAOK2 | 0.93881508 |
48 | RIPK1 | 0.93874984 |
49 | SIK2 | 0.93737121 |
50 | MAP3K2 | 0.92653071 |
51 | LIMK1 | 0.89722234 |
52 | IRAK2 | 0.87579172 |
53 | PTK2B | 0.87073504 |
54 | KDR | 0.86523132 |
55 | LYN | 0.80050594 |
56 | ITK | 0.79750871 |
57 | TAOK1 | 0.78891446 |
58 | CSF1R | 0.78645021 |
59 | CDK19 | 0.78643926 |
60 | TYK2 | 0.76754309 |
61 | BMPR2 | 0.75886233 |
62 | IKBKB | 0.75231980 |
63 | MAP3K5 | 0.72991128 |
64 | SMG1 | 0.71117741 |
65 | PIM1 | 0.70771746 |
66 | MAP3K7 | 0.70740658 |
67 | MAP3K6 | 0.69144514 |
68 | MAP3K8 | 0.68920348 |
69 | TNK2 | 0.68279956 |
70 | MARK3 | 0.68155042 |
71 | FYN | 0.67758422 |
72 | LCK | 0.67381386 |
73 | TGFBR2 | 0.66558489 |
74 | RPS6KA2 | 0.64461842 |
75 | MAP3K14 | 0.63603078 |
76 | WEE1 | 0.63122565 |
77 | TBK1 | 0.58800411 |
78 | RET | 0.58704566 |
79 | DYRK1B | 0.57458344 |
80 | PRKCD | 0.57057201 |
81 | CDC42BPA | 0.56146423 |
82 | MAP3K1 | 0.55753043 |
83 | MAPKAPK2 | 0.54126489 |
84 | YES1 | 0.53900488 |
85 | RPS6KL1 | 0.53815415 |
86 | RPS6KC1 | 0.53815415 |
87 | MAPK12 | 0.53563232 |
88 | IRAK3 | 0.52488998 |
89 | MATK | 0.51866863 |
90 | STK4 | 0.51681469 |
91 | SIK1 | 0.51437834 |
92 | DMPK | 0.50677591 |
93 | RPS6KA6 | 0.50442387 |
94 | JAK2 | 0.50058719 |
95 | PRKCH | 0.48772647 |
96 | SGK3 | 0.47067600 |
97 | RAF1 | 0.46827645 |
98 | MAPK7 | 0.46619952 |
99 | PDPK1 | 0.46150284 |
100 | KSR1 | 0.45658341 |
101 | HIPK2 | 0.44000082 |
102 | FGFR4 | 0.43865828 |
103 | PDK1 | 0.41913374 |
104 | STK38 | 0.41394496 |
105 | MAPK11 | 0.41037236 |
106 | STK11 | 0.40497509 |
107 | EGFR | 0.39242884 |
108 | MAP3K3 | 0.38329890 |
109 | DAPK2 | 0.37702493 |
110 | PRKCQ | 0.37566398 |
111 | CAMK1G | 0.37554412 |
112 | CAMK1D | 0.36213034 |
113 | PIK3CG | 0.31323851 |
114 | ABL1 | 0.31283769 |
115 | STK24 | 0.30482296 |
116 | PRKAA2 | 0.29819525 |
117 | BRSK2 | 0.29390486 |
118 | KIT | 0.29330047 |
119 | JAK1 | 0.28704318 |
120 | TXK | 0.28680372 |
121 | RPS6KA1 | 0.27890729 |
122 | PRKD1 | 0.27444554 |
123 | GRK7 | 0.26935157 |
124 | BMX | 0.25631184 |
125 | EPHA3 | 0.24595419 |
126 | FGFR3 | 0.23947199 |
127 | IKBKE | 0.23336709 |
128 | TAOK3 | 0.22656423 |
129 | SRC | 0.22465596 |
130 | PRKG1 | 0.21909015 |
131 | ILK | 0.21888951 |
132 | CDK6 | 0.21646418 |
133 | PRKACG | 0.21475313 |
134 | PRKCZ | 0.18859530 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 4.52490854 |
2 | Asthma_Homo sapiens_hsa05310 | 3.64119040 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.62404128 |
4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 3.23277587 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.11041651 |
6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.96207704 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68517710 |
8 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.09751434 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.05343215 |
10 | Shigellosis_Homo sapiens_hsa05131 | 2.03879041 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99637418 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.95691424 |
13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.90942445 |
14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.87506905 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84660707 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82199217 |
17 | Pertussis_Homo sapiens_hsa05133 | 1.80811594 |
18 | Platelet activation_Homo sapiens_hsa04611 | 1.72086286 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70156428 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62894671 |
21 | Phagosome_Homo sapiens_hsa04145 | 1.61814523 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58938285 |
23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55300122 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50201914 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.50034329 |
26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48037870 |
27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42476450 |
28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42374865 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42359858 |
30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.40796158 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37047433 |
32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33625621 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29273745 |
34 | Legionellosis_Homo sapiens_hsa05134 | 1.29196080 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28063389 |
36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26027582 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15309237 |
38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08003918 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.04315430 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01924889 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 1.01357295 |
42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01299837 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01256820 |
44 | Amoebiasis_Homo sapiens_hsa05146 | 0.96322863 |
45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94603507 |
46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93693212 |
47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92558817 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92321584 |
49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92092510 |
50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90049957 |
51 | Malaria_Homo sapiens_hsa05144 | 0.89088019 |
52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89012760 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88958780 |
54 | Bladder cancer_Homo sapiens_hsa05219 | 0.87914051 |
55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86063185 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84998906 |
57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82818629 |
58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82811001 |
59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82601319 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82209245 |
61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81833161 |
62 | Apoptosis_Homo sapiens_hsa04210 | 0.77833805 |
63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76734028 |
64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76311867 |
65 | Influenza A_Homo sapiens_hsa05164 | 0.75476438 |
66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75415832 |
67 | Measles_Homo sapiens_hsa05162 | 0.74874488 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.73910402 |
69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73212727 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72584012 |
71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71727490 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.69914470 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69601736 |
74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67640046 |
75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66916781 |
76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66823095 |
77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66514406 |
78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66240571 |
79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64278237 |
80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63818880 |
81 | ABC transporters_Homo sapiens_hsa02010 | 0.60899893 |
82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60552926 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59220585 |
84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58852069 |
85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58354158 |
86 | Glioma_Homo sapiens_hsa05214 | 0.56936501 |
87 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56903894 |
88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56589938 |
89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56374432 |
90 | Lysosome_Homo sapiens_hsa04142 | 0.55238016 |
91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54841838 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54517993 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54208760 |
94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53302817 |
95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52882455 |
96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51969495 |
97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51702842 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50339779 |
99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49885275 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48539715 |
101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48425623 |
102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47931690 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47466764 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46548014 |
105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46504996 |
106 | Focal adhesion_Homo sapiens_hsa04510 | 0.46304301 |
107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44786576 |
108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44059237 |
109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43984991 |
110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43505837 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43404370 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42847517 |
113 | Cell cycle_Homo sapiens_hsa04110 | 0.42263983 |
114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42053108 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41628045 |
116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41626334 |
117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40266922 |
118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39870828 |
119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39732817 |
120 | Adherens junction_Homo sapiens_hsa04520 | 0.37312379 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35991831 |
122 | Salivary secretion_Homo sapiens_hsa04970 | 0.33865623 |
123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32075272 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31521511 |